Arimidex vs. Tamoxifen
Links shared publicly online about this topic
Long-term ATAC results confirm superior efficacy, safety of anastrozole vs. tamoxifen for early breast cancer | HemOncToday
hemonctoday.com — “The 10-year follow-up results of the ATAC trial have confirmed the superior efficacy and safety of the aromatase inhibitor anastrozole compar” View full resource at hemonctoday.com
Most Recently Shared on November 29, 2010 at 9:23 pm By:
HemOnc Today Oncology and Health News
Long-term ATAC results confirm superior efficacy, safety of anastrozole vs. tamoxifen for early breast cancer http://bit.ly/hztbGk
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial : The Lancet Oncology
thelancet.com — “Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. By - Prof Jack Cuzick PhD, Ivana Sestak PhD, Prof Michael Baum MD, Prof ...” View full resource at thelancet.com
Most Recently Shared on November 17, 2010 at 2:38 pm By:
Long-term outcomes of the ATAC trial in postmenopausal women with early-stage breast cancer. http://bit.ly/cKCoAI #Oncology
Effect of Body Mass Index on Recurrences in Tamoxifen and Anastrozole Treated Women: An Exploratory Analysis From the ATAC Trial -- Sestak et al., 10.1200/JCO.2009.27.2021 -- Journal of Clinical Oncology
jco.ascopubs.org — “Effect of Body Mass Index on Recurrences in Tamoxifen and Anastrozole Treated Women: An Exploratory Analysis From the ATAC Trial -- Sestak et al., 10.1200/JCO.2009.27.2021 -- Journal of Clinical Oncology” View full resource at jco.ascopubs.org
Most Recently Shared on June 15, 2010 at 8:06 am By:
Dr Steven Tucker Oncologist, Physician, Doctor, and Internist
More #breast #cancer recurrences for women with high BMI vs. low BMI. http://bit.ly/bYQXbS #oncology
Medical News: ASCO Breast: Ten Years On, Anastrazole Still Tops SERM - in Meeting Coverage, ASCO Breast from MedPage Today
medpagetoday.com — “NATIONAL HARBOR, Md. -- The aromatase inhibitor anastrozole (Arimidex) extended its disease control advantage over tamoxifen in an analysis of 10-year outcomes in a large randomized clinical trial in” View full resource at medpagetoday.com
Most Recently Shared on October 4, 2010 at 12:20 am By:
ASCO Breast: Ten Years On, Anastrazole Still Tops SERM http://bit.ly/cJynSK
I am a male and had breast cancer in 1995.I had stage 2 with 1 lymgh node cancer. - Breast Cancer
healthcentral.com — “I am 73 yrs. old.I had chemo. and went on tamoxifen for 12 yrs. I am on Arimidex now.Should a male be on Arimidex....” View full resource at healthcentral.com
Most Recently Shared on August 12, 2011 at 5:38 pm By:
HealthCentral Tips Health Site
@Bri_Neva_Press_ The answer is yes: men can get breast cancer. More info: http://j.mp/okDkg8 One man's story: http://j.mp/nEc9Ww
ASCO Breast: Ten Years On, Anastrazole Still Tops SERM - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- NATIONAL HARBOR, Md. -- The aromatase inhibitor anastrozole (Arimidex) extended its disease control advantage over tamoxifen in an analysis of 10-year outcomes in a large randomized clinical trial in breast cancer.” View full resource at qualitypointtech.net
Most Recently Shared on October 3, 2010 at 11:36 pm By:
ASCO Breast: Ten Years On, Anastrazole Still Tops SERM: (MedPage Today) -- NATIONAL HARBOR, Md. -- The aromatase i... http://bit.ly/cxT853
Cancer Blog - tzalley's Cancer Blog: Femara
tzalley.blogforacure.com — “Anyone taking femara for post adjuvant treatment. Was wondering when side effects would start if I was going to have them.. So far after 3.5 weeks if just a few hot flashes that are more than managable and a few episodes of extreme irritablity. I was on Arimidex a couple of years ago but had to go back to Tamoxifen due to the extreme fatigue and walking was becoming almost impossible due to the pa” View full resource at tzalley.blogforacure.com
Most Recently Shared on March 5, 2010 at 5:30 am By:
Femara: Anyone taking femara for post adjuvant treatment. Was wondering when side effects would start if I was goi... http://bit.ly/bhuVel
Adjuvants, Pharmaceutic Tamoxifen on #MDlinx
mdlinx.com — “Adjuvants, Pharmaceutic Tamoxifen on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 5, 2010 at 7:13 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxi... http://bit.ly/9RJNMb #oncology
More on Tamoxifen Risks vs benefits - Home - Nurse For Health
nurseforhealth.com — “More on Tamoxifen Risks vs benefits - Home - Nurse For Health” View full resource at nurseforhealth.com
Most Recently Shared on April 25, 2012 at 7:39 am By:
In Oct. of 2009, Sue became a Certified Natural Health Professional, and
in 2011 became Certified as a Digestive Health Specialist through the
Loomis Institute of Enzyme Nutrition, and is also a member of the
American Holistic Nurses Association. Sue has a private practice in
Green Bay, WI., but has the priviledge of having and serving clients in
areas of Nova Scotia, Boston, Minnesota, West Virginia, and the Fox
Valley area of WI. She maintains her current WI Nursing Licensure. We welcome you to
contact us about cancer-fighting supplements used in Sue's treatment.
" /> Suzan Macco RN, CNHP, Loomis Digestive Health Specialist Nurse and Active Health Library
Tamoxifen Metabolism and CYP2D6: eMedicine Genomic Medicine
emedicine.medscape.com — “Overview: Adjuvant therapy with tamoxifen has been the standard approach for reducing risk of recurrence in women with estrogen-receptor (ER) positive breast cancer since the early 1980s. Long-term data demonstrate that the use of tamoxifen reduces recurrence and ...” View full resource at emedicine.medscape.com
Most Recently Shared on June 2, 2010 at 7:23 pm By:
Susan Scroggins Active Health Library and Health Advocate
Learn about tamoxifen (a chemotherapy medication) metabolism and CYP2D6. http://bit.ly/cM2RiB
Study Shows Novartis Drug Afinitor Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients - Drugs.com MedNews
drugs.com — “Randomized Phase II study shows 61 of advanced breast cancer patients on everolimus plus tamoxifen had no tumor progression at six months vs. 42 on tamoxifen al” View full resource at drugs.com
Most Recently Shared on December 9, 2010 at 7:07 pm By:
Drugs and Devices OW OW Health
Study Shows Novartis Drug Afinitor Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic... http://bit.ly/hWpgeE #drug
Considering My Options Without Femara - Breast Cancer Blog
everydayhealth.com — “After writing my last blog on my decision to stop taking Femara, I wrestled all weekend with whether if that was the right thing to do.” View full resource at everydayhealth.com
Most Recently Shared on December 7, 2010 at 9:15 pm By:
Wrestling with the decision to take hormonal drugs after #breastcancer isn't easy. One blogger weighs her options http://ow.ly/3liRg
BlogPost - Elizabeth Edwards and the cancer question
voices.washingtonpost.com — “BlogPost - Elizabeth Edwards and the cancer question” View full resource at voices.washingtonpost.com
Most Recently Shared on December 10, 2010 at 9:15 pm By:
@EverydayHealth breast cancer blogger featured on @washingtonpost http://ow.ly/3noRg Read Kathy-Ellen's latest: http://ow.ly/3noTp
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
HemOnc Today
The official Twitter feed for HemOnc Today, offering news and perspectives in hematology and oncology.
-
The Lancet
Welcome to the Lancet.com on Twitter. Keep in touch with The Lancet, the world's leading general medical journal.
-
Dr Steven Tucker
A US ex-pat doctor in Asia. The more you think about your health the more you can improve it.
Advertisement
